"Designing Growth Strategies is in our DNA"

Biologics Safety Testing Market Size, Share & Industry Analysis, By Products & Services (Kits & Reagents, Instruments, and Services), By Test Type (Sterility, Endotoxin/Pyrogen, Mycoplasma, Bioburden, Viral Safety/Adventitious Agents, Residual HCP/HCDNA, Cell Line Characterization, and Others), By Application (mAbs & Recombinant Proteins, Vaccines, Cell & Gene Therapies, Blood & Plasma Products, and Tissue/Stem Cell Products), By End User (Pharma & Biotech Companies, CROs/CDMOs, Academic & Research Institutes, and Government/Regulatory Labs), and Regional Forecast, 2025-2032

Last Updated: December 19, 2025 | Format: PDF | Report ID: FBI114846

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Technological Advancements in Healthcare Chatbots
    2. Overview: Implementation and Applications of Biologics Safety Testing
    3. Regulatory Scenario, By Key Countries/Regions
    4. New Product Launches, By Key Players
    5. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches)
  5. Global Biologics Safety Testing Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Products & Services
      1. Kits & Reagents
      2. Instruments
      3. Services
    2. Market Analysis, Insights and Forecast – By Test Type
      1. Sterility
      2. Endotoxin/Pyrogen
      3. Mycoplasma
      4. Bioburden
      5. Viral Safety / Adventitious Agents
      6. Residual HCP/HCDNA
      7. Cell Line Characterization
      8. Others
    3. Market Analysis, Insights and Forecast – By Application
      1. mAbs & Recombinant Proteins
      2. Vaccines
      3. Cell & Gene Therapies
      4. Blood & Plasma Products
      5. Tissue/Stem Cell Products
    4. Market Analysis, Insights and Forecast – By End User
      1. Pharma & Biotech Companies
      2. CROs/CDMOs
      3. Academic & Research Institutes
      4. Government/Regulatory Labs
    5. Market Analysis, Insights and Forecast – Region
      1.  North America
      2.  Europe
      3.  Asia Pacific
      4.  Latin America
      5.  Middle East & Africa
  6. North America Biologics Safety Testing Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Products & Services
      1. Kits & Reagents
      2. Instruments
      3. Services
    2. Market Analysis, Insights and Forecast – By Test Type
      1. Sterility
      2. Endotoxin/Pyrogen
      3. Mycoplasma
      4. Bioburden
      5. Viral Safety / Adventitious Agents
      6. Residual HCP/HCDNA
      7. Cell Line Characterization
      8. Others
    3. Market Analysis, Insights and Forecast – By Application
      1. mAbs & Recombinant Proteins
      2. Vaccines
      3. Cell & Gene Therapies
      4. Blood & Plasma Products
      5. Tissue/Stem Cell Products
    4. Market Analysis, Insights and Forecast – By End User
      1. Pharma & Biotech Companies
      2. CROs/CDMOs
      3. Academic & Research Institutes
      4. Government/Regulatory Labs
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada 
  7. Europe Biologics Safety Testing Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Products & Services
      1. Kits & Reagents
      2. Instruments
      3. Services
    2. Market Analysis, Insights and Forecast – By Test Type
      1. Sterility
      2. Endotoxin/Pyrogen
      3. Mycoplasma
      4. Bioburden
      5. Viral Safety / Adventitious Agents
      6. Residual HCP/HCDNA
      7. Cell Line Characterization
      8. Others
    3. Market Analysis, Insights and Forecast – By Application
      1. mAbs & Recombinant Proteins
      2. Vaccines
      3. Cell & Gene Therapies
      4. Blood & Plasma Products
      5. Tissue/Stem Cell Products
    4. Market Analysis, Insights and Forecast – By End User
      1. Pharma & Biotech Companies
      2. CROs/CDMOs
      3. Academic & Research Institutes
      4. Government/Regulatory Labs
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. U.K.
      2. Germany 
      3. France 
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Biologics Safety Testing Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Products & Services
      1. Kits & Reagents
      2. Instruments
      3. Services
    2. Market Analysis, Insights and Forecast – By Test Type
      1. Sterility
      2. Endotoxin/Pyrogen
      3. Mycoplasma
      4. Bioburden
      5. Viral Safety / Adventitious Agents
      6. Residual HCP/HCDNA
      7. Cell Line Characterization
      8. Others
    3. Market Analysis, Insights and Forecast – By Application
      1. mAbs & Recombinant Proteins
      2. Vaccines
      3. Cell & Gene Therapies
      4. Blood & Plasma Products
      5. Tissue/Stem Cell Products
    4. Market Analysis, Insights and Forecast – By End User
      1. Pharma & Biotech Companies
      2. CROs/CDMOs
      3. Academic & Research Institutes
      4. Government/Regulatory Labs
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. China
      2. Japan
      3. India
      4. Southeast Asia
      5. Australia
      6. Rest of Asia Pacific
  9. Latin America Biologics Safety Testing Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Products & Services
      1. Kits & Reagents
      2. Instruments
      3. Services
    2. Market Analysis, Insights and Forecast – By Test Type
      1. Sterility
      2. Endotoxin/Pyrogen
      3. Mycoplasma
      4. Bioburden
      5. Viral Safety / Adventitious Agents
      6. Residual HCP/HCDNA
      7. Cell Line Characterization
      8. Others
    3. Market Analysis, Insights and Forecast – By Application
      1. mAbs & Recombinant Proteins
      2. Vaccines
      3. Cell & Gene Therapies
      4. Blood & Plasma Products
      5. Tissue/Stem Cell Products
    4. Market Analysis, Insights and Forecast – By End User
      1. Pharma & Biotech Companies
      2. CROs/CDMOs
      3. Academic & Research Institutes
      4. Government/Regulatory Labs
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Biologics Safety Testing Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Products & Services
      1. Kits & Reagents
      2. Instruments
      3. Services
    2. Market Analysis, Insights and Forecast – By Test Type
      1. Sterility
      2. Endotoxin/Pyrogen
      3. Mycoplasma
      4. Bioburden
      5. Viral Safety / Adventitious Agents
      6. Residual HCP/HCDNA
      7. Cell Line Characterization
      8. Others
    3. Market Analysis, Insights and Forecast – By Application
      1. mAbs & Recombinant Proteins
      2. Vaccines
      3. Cell & Gene Therapies
      4. Blood & Plasma Products
      5. Tissue/Stem Cell Products
    4. Market Analysis, Insights and Forecast – By End User
      1. Pharma & Biotech Companies
      2. CROs/CDMOs
      3. Academic & Research Institutes
      4. Government/Regulatory Labs
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. GCC 
      2. South Africa
      3. Rest of the Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2024)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Merck KGaA
      2. SGS Société Générale de Surveillance SA
      3. Thermo Fisher Scientific Inc. 
      4. BD
      5. Sartorius AG
      6. Charles River Laboratories
      7. Eurofins Scientific 
      8. Lonza
      9. Waters Corporation
      10. Reading Scientific Services Ltd
      11. Abzena
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Technological Advancements in Healthcare Chatbots
    2. Overview: Implementation and Applications of Biologics Safety Testing
    3. Regulatory Scenario, By Key Countries/Regions
    4. New Product Launches, By Key Players
    5. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches)
  5. Global Biologics Safety Testing Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Products & Services
      1. Kits & Reagents
      2. Instruments
      3. Services
    2. Market Analysis, Insights and Forecast – By Test Type
      1. Sterility
      2. Endotoxin/Pyrogen
      3. Mycoplasma
      4. Bioburden
      5. Viral Safety / Adventitious Agents
      6. Residual HCP/HCDNA
      7. Cell Line Characterization
      8. Others
    3. Market Analysis, Insights and Forecast – By Application
      1. mAbs & Recombinant Proteins
      2. Vaccines
      3. Cell & Gene Therapies
      4. Blood & Plasma Products
      5. Tissue/Stem Cell Products
    4. Market Analysis, Insights and Forecast – By End User
      1. Pharma & Biotech Companies
      2. CROs/CDMOs
      3. Academic & Research Institutes
      4. Government/Regulatory Labs
    5. Market Analysis, Insights and Forecast – Region
      1.  North America
      2.  Europe
      3.  Asia Pacific
      4.  Latin America
      5.  Middle East & Africa
  6. North America Biologics Safety Testing Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Products & Services
      1. Kits & Reagents
      2. Instruments
      3. Services
    2. Market Analysis, Insights and Forecast – By Test Type
      1. Sterility
      2. Endotoxin/Pyrogen
      3. Mycoplasma
      4. Bioburden
      5. Viral Safety / Adventitious Agents
      6. Residual HCP/HCDNA
      7. Cell Line Characterization
      8. Others
    3. Market Analysis, Insights and Forecast – By Application
      1. mAbs & Recombinant Proteins
      2. Vaccines
      3. Cell & Gene Therapies
      4. Blood & Plasma Products
      5. Tissue/Stem Cell Products
    4. Market Analysis, Insights and Forecast – By End User
      1. Pharma & Biotech Companies
      2. CROs/CDMOs
      3. Academic & Research Institutes
      4. Government/Regulatory Labs
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada 
  7. Europe Biologics Safety Testing Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Products & Services
      1. Kits & Reagents
      2. Instruments
      3. Services
    2. Market Analysis, Insights and Forecast – By Test Type
      1. Sterility
      2. Endotoxin/Pyrogen
      3. Mycoplasma
      4. Bioburden
      5. Viral Safety / Adventitious Agents
      6. Residual HCP/HCDNA
      7. Cell Line Characterization
      8. Others
    3. Market Analysis, Insights and Forecast – By Application
      1. mAbs & Recombinant Proteins
      2. Vaccines
      3. Cell & Gene Therapies
      4. Blood & Plasma Products
      5. Tissue/Stem Cell Products
    4. Market Analysis, Insights and Forecast – By End User
      1. Pharma & Biotech Companies
      2. CROs/CDMOs
      3. Academic & Research Institutes
      4. Government/Regulatory Labs
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. U.K.
      2. Germany 
      3. France 
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Biologics Safety Testing Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Products & Services
      1. Kits & Reagents
      2. Instruments
      3. Services
    2. Market Analysis, Insights and Forecast – By Test Type
      1. Sterility
      2. Endotoxin/Pyrogen
      3. Mycoplasma
      4. Bioburden
      5. Viral Safety / Adventitious Agents
      6. Residual HCP/HCDNA
      7. Cell Line Characterization
      8. Others
    3. Market Analysis, Insights and Forecast – By Application
      1. mAbs & Recombinant Proteins
      2. Vaccines
      3. Cell & Gene Therapies
      4. Blood & Plasma Products
      5. Tissue/Stem Cell Products
    4. Market Analysis, Insights and Forecast – By End User
      1. Pharma & Biotech Companies
      2. CROs/CDMOs
      3. Academic & Research Institutes
      4. Government/Regulatory Labs
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. China
      2. Japan
      3. India
      4. Southeast Asia
      5. Australia
      6. Rest of Asia Pacific
  9. Latin America Biologics Safety Testing Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Products & Services
      1. Kits & Reagents
      2. Instruments
      3. Services
    2. Market Analysis, Insights and Forecast – By Test Type
      1. Sterility
      2. Endotoxin/Pyrogen
      3. Mycoplasma
      4. Bioburden
      5. Viral Safety / Adventitious Agents
      6. Residual HCP/HCDNA
      7. Cell Line Characterization
      8. Others
    3. Market Analysis, Insights and Forecast – By Application
      1. mAbs & Recombinant Proteins
      2. Vaccines
      3. Cell & Gene Therapies
      4. Blood & Plasma Products
      5. Tissue/Stem Cell Products
    4. Market Analysis, Insights and Forecast – By End User
      1. Pharma & Biotech Companies
      2. CROs/CDMOs
      3. Academic & Research Institutes
      4. Government/Regulatory Labs
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Biologics Safety Testing Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Products & Services
      1. Kits & Reagents
      2. Instruments
      3. Services
    2. Market Analysis, Insights and Forecast – By Test Type
      1. Sterility
      2. Endotoxin/Pyrogen
      3. Mycoplasma
      4. Bioburden
      5. Viral Safety / Adventitious Agents
      6. Residual HCP/HCDNA
      7. Cell Line Characterization
      8. Others
    3. Market Analysis, Insights and Forecast – By Application
      1. mAbs & Recombinant Proteins
      2. Vaccines
      3. Cell & Gene Therapies
      4. Blood & Plasma Products
      5. Tissue/Stem Cell Products
    4. Market Analysis, Insights and Forecast – By End User
      1. Pharma & Biotech Companies
      2. CROs/CDMOs
      3. Academic & Research Institutes
      4. Government/Regulatory Labs
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. GCC 
      2. South Africa
      3. Rest of the Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2024)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Merck KGaA
      2. SGS Société Générale de Surveillance SA
      3. Thermo Fisher Scientific Inc. 
      4. BD
      5. Sartorius AG
      6. Charles River Laboratories
      7. Eurofins Scientific 
      8. Lonza
      9. Waters Corporation
      10. Reading Scientific Services Ltd
      11. Abzena
Read Less

Figure 1: Global Biologics Safety Testing Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2: Global Biologics Safety Testing Market Value Share (%), By Products & Services, 2025 & 2034

Figure 3: Global Biologics Safety Testing Market Value Share (%), by Test Type, 2025 & 2034

Figure 4: Global Biologics Safety Testing Market Value Share (%), by Application, 2025 & 2034

Figure 5: Global Biologics Safety Testing Market Value Share (%), by End User, 2025 & 2034

Figure 6: Global Biologics Safety Testing Market Value Share (%), by Region, 2025 & 2034

Figure 7: North America Biologics Safety Testing Market Value (USD billion), By Products & Services, 2025 & 2034

Figure 8: North America Biologics Safety Testing Market Value Share (%), By Products & Services, 2025

Figure 9: North America Biologics Safety Testing Market Value (USD billion), by Test Type 2025 & 2034

Figure 10: North America Biologics Safety Testing Market Value Share (%), by Test Type 2025

Figure 11: North America Biologics Safety Testing Market Value (USD billion), by Application, 2025 & 2034

Figure 12: North America Biologics Safety Testing Market Value Share (%), by Application, 2025

Figure 13: North America Biologics Safety Testing Market Value (USD billion), by End User, 2025 & 2034

Figure 14: North America Biologics Safety Testing Market Value Share (%), by End User, 2025

Figure 15: North America Biologics Safety Testing Market Value (USD billion), by Country, 2025 & 2034

Figure 16: North America Biologics Safety Testing Market Value Share (%), by Country, 2025

Figure 17: Europe Biologics Safety Testing Market Value (USD billion), By Products & Services, 2025 & 2034

Figure 18: Europe Biologics Safety Testing Market Value Share (%), By Products & Services, 2025

Figure 19: Europe Biologics Safety Testing Market Value (USD billion), by Test Type 2025 & 2034

Figure 20: Europe Biologics Safety Testing Market Value Share (%), by Test Type 2025

Figure 21: Europe Biologics Safety Testing Market Value (USD billion), by Application, 2025 & 2034

Figure 22: Europe Biologics Safety Testing Market Value Share (%), by Application, 2025

Figure 23: Europe Biologics Safety Testing Market Value (USD billion), by End User, 2025 & 2034

Figure 24: Europe Biologics Safety Testing Market Value Share (%), by End User, 2025

Figure 25: Europe Biologics Safety Testing Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 26: Europe Biologics Safety Testing Market Value Share (%), by Country/ Sub-region, 2025

Figure 27: Asia Pacific Biologics Safety Testing Market Value (USD billion), By Products & Services, 2025 & 2034

Figure 28: Asia Pacific Biologics Safety Testing Market Value Share (%), By Products & Services, 2025

Figure 29: Asia Pacific Biologics Safety Testing Market Value (USD billion), by Test Type 2025 & 2034

Figure 30: Asia Pacific Biologics Safety Testing Market Value Share (%), by Test Type 2025

Figure 31: Asia Pacific Biologics Safety Testing Market Value (USD billion), by Application, 2025 & 2034

Figure 32: Asia Pacific Biologics Safety Testing Market Value Share (%), by Application, 2025

Figure 33: Asia Pacific Biologics Safety Testing Market Value (USD billion), by End User, 2025 & 2034

Figure 34: Asia Pacific Biologics Safety Testing Market Value Share (%), by End User, 2025

Figure 35: Asia Pacific Biologics Safety Testing Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 36: Asia Pacific Biologics Safety Testing Market Value Share (%), by Country/ Sub-region, 2025

Figure 37: Latin America Biologics Safety Testing Market Value (USD billion), By Products & Services, 2025 & 2034

Figure 38: Latin America Biologics Safety Testing Market Value Share (%), By Products & Services, 2025

Figure 39: Latin America Biologics Safety Testing Market Value (USD billion), by Test Type 2025 & 2034

Figure 40: Latin America Biologics Safety Testing Market Value Share (%), by Test Type 2025

Figure 41: Latin America Biologics Safety Testing Market Value (USD billion), by Application, 2025 & 2034

Figure 42: Latin America Biologics Safety Testing Market Value Share (%), by Application, 2025

Figure 43: Latin America Biologics Safety Testing Market Value (USD billion), by End User, 2025 & 2034

Figure 44: Latin America Biologics Safety Testing Market Value Share (%), by End User, 2025

Figure 45: Latin America Biologics Safety Testing Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 46: Latin America Biologics Safety Testing Market Value Share (%), by Country/ Sub-region, 2025

Figure 47: Middle East & Africa Biologics Safety Testing Market Value (USD billion), By Products & Services, 2025 & 2034

Figure 48: Middle East & Africa Biologics Safety Testing Market Value Share (%), By Products & Services, 2025

Figure 49: Middle East & Africa Biologics Safety Testing Market Value (USD billion), by Test Type 2025 & 2034

Figure 50: Middle East & Africa Biologics Safety Testing Market Value Share (%), by Test Type 2025

Figure 51: Middle East & Africa Biologics Safety Testing Market Value (USD billion), by Application, 2025 & 2034

Figure 52: Middle East & Africa Biologics Safety Testing Market Value Share (%), by Application, 2025

Figure 53: Middle East & Africa Biologics Safety Testing Market Value (USD billion), by End User, 2025 & 2034

Figure 54: Middle East & Africa Biologics Safety Testing Market Value Share (%), by End User, 2025

Figure 55: Middle East & Africa Biologics Safety Testing Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 56: Middle East & Africa Biologics Safety Testing Market Value Share (%), by Country/ Sub-region, 2025

Figure 57: Global Biologics Safety Testing Market Share (%), by Company, 2025

Table 1: Global Biologics Safety Testing Market Revenue (USD billion) Forecast, By Products & Services, 2021–2034

Table 2: Global Biologics Safety Testing Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 3: Global Biologics Safety Testing Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 4: Global Biologics Safety Testing Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 5: Global Biologics Safety Testing Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 6: North America Biologics Safety Testing Market Revenue (USD billion) Forecast, By Products & Services, 2021–2034

Table 7: North America Biologics Safety Testing Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 8: North America Biologics Safety Testing Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 9: North America Biologics Safety Testing Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 10: North America Biologics Safety Testing Market Revenue (USD billion) Forecast, by Country, 2019-2032

Table 11: Europe Biologics Safety Testing Market Revenue (USD billion) Forecast, By Products & Services, 2021–2034

Table 12: Europe Biologics Safety Testing Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 13: Europe Biologics Safety Testing Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 14: Europe Biologics Safety Testing Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 15: Europe Biologics Safety Testing Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2019-2032

Table 16: Asia Pacific Biologics Safety Testing Market Revenue (USD billion) Forecast, By Products & Services, 2021–2034

Table 17: Asia Pacific Biologics Safety Testing Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 18: Asia Pacific Biologics Safety Testing Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 19: Asia Pacific Biologics Safety Testing Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 20: Asia Pacific Biologics Safety Testing Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2019-2032

Table 21: Latin America Biologics Safety Testing Market Revenue (USD billion) Forecast, By Products & Services, 2021–2034

Table 22: Latin America Biologics Safety Testing Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 23: Latin America Biologics Safety Testing Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 24: Latin America Biologics Safety Testing Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 25: Latin America Biologics Safety Testing Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2019-2032

Table 26: Middle East & Africa Biologics Safety Testing Market Revenue (USD billion) Forecast, By Products & Services, 2021–2034

Table 27: Middle East & Africa Biologics Safety Testing Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 28: Middle East & Africa Biologics Safety Testing Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 29: Middle East & Africa Biologics Safety Testing Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 30: Middle East & Africa Biologics Safety Testing Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2019-2032

  • 2019-2032
  • 2024
  • 2019-2023
  • 167
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann